Brief: CMS Announces Manufacturer Participation in Second Cycle of Medicare Drug Price Negotiation
14/03/2025 21:56
March 14 (Reuters) - CMS: DEALS SIGNED WITH MANUFACTURERS OF 15 DRUGS COVERED UNDER MEDICARE PART D SELECTED FOR SECOND CYCLE OF MEDICARE DRUG PRICE NEGOTIATION PROGRAM ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Astellas Pharma
See all newsBrief: Immuneering To Collaborate With Astellas On Clinical Studies Of Investigational CLDN18.2 Programs In Combination With Atebimetinib For Pancreatic Cancer Patients
Health Rounds: New blood test finds early risk for ovarian cancer
Health Rounds: New blood test finds early risk for ovarian cancer
Refile: Astellas employee imprisoned in China to be released in December, Japanese media report
Table: Astellas Pharma -6-MTH group results (IFRS)